The Improving Treatment Environment and Survivorship for Multiple Myeloma grant from Pfizer supports medical educational projects for healthcare professionals that accelerate the improvement of treatment environments for multiple myeloma patients regarding diagnosis, treatment, comprehensive care and social support. Applicants must be based in Japan. The following organizations may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
Applicants may apply for up to 7 million JPY (including up to 28% overheads).
Applications close on June 30, 2023.
